These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 35845008)

  • 1. Clinical features of anthracycline-induced cardiotoxicity in patients with malignant lymphoma who received a CHOP regimen with or without rituximab: A single-center, retrospective observational study.
    Nakayama T; Oshima Y; Kusumoto S; Yamamoto J; Osaga S; Fujinami H; Kikuchi T; Suzuki T; Totani H; Kinoshita S; Narita T; Ito A; Ri M; Komatsu H; Wakami K; Goto T; Sugiura T; Seo Y; Ohte N; Iida S
    EJHaem; 2020 Nov; 1(2):498-506. PubMed ID: 35845008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiotoxicity with rituximab, cyclophosphamide, non-pegylated liposomal doxorubicin, vincristine and prednisolone compared to rituximab, cyclophosphamide, doxorubicin, vincristine, and prednisolone in frontline treatment of patients with diffuse large B-cell lymphoma: A randomised phase-III study from the Austrian Cancer Drug Therapy Working Group [Arbeitsgemeinschaft Medikamentöse Tumortherapie AGMT](NHL-14).
    Fridrik MA; Jaeger U; Petzer A; Willenbacher W; Keil F; Lang A; Andel J; Burgstaller S; Krieger O; Oberaigner W; Sihorsch K; Greil R
    Eur J Cancer; 2016 May; 58():112-21. PubMed ID: 26990931
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incidence and risk-factors of CHOP/R-CHOP-related cardiotoxicity in patients with aggressive non-Hodgkin's lymphoma.
    Limat S; Daguindau E; Cahn JY; Nerich V; Brion A; Perrin S; Woronoff-Lemsi MC; Deconinck E
    J Clin Pharm Ther; 2014 Apr; 39(2):168-74. PubMed ID: 24384030
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Speckle tracking echocardiography in the early detection and prediction of anthracycline cardiotoxicity in diffuse large B-cell lymphoma treated with (R)-CHOP regimen.
    Wang B; Yu Y; Zhang Y; Hao X; Zhao H; Yang S; Sun Q; Wang Y
    Echocardiography; 2020 Mar; 37(3):421-428. PubMed ID: 32112477
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cardiotoxicity as indicated by LVEF and troponin T sensitivity following two anthracycline-based regimens in lymphoma: Results from a randomized prospective clinical trial.
    Xue K; Gu JJ; Zhang Q; Liu X; Wang J; Li XQ; Luo J; Hernandez-Ilizaliturri FJ; Fernandez SF; Czuczman MS; Cao J; Hong X; Guo Y
    Oncotarget; 2016 May; 7(22):32519-31. PubMed ID: 27081036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ventricular Sigmoid Septum as a Risk Factor for Anthracycline-Induced Cancer Therapeutics-Related Cardiac Dysfunction in Patients With Malignant Lymphoma.
    Nakayama T; Oshima Y; Shintani Y; Yamamoto J; Yokoi M; Ito T; Wakami K; Kitada S; Goto T; Hashimoto H; Kusumoto S; Sugiura T; Iida S; Seo Y
    Circ Rep; 2022 Apr; 4(4):173-182. PubMed ID: 35434414
    [No Abstract]   [Full Text] [Related]  

  • 7. [Early detection of the cardiotoxicity induced by chemotherapy drug through two-dimensional speckle tracking echocardiography combined with high-sensitive cardiac troponin T].
    Wang W; Kang Y; Shu XH; Shen XD; He B
    Zhonghua Zhong Liu Za Zhi; 2017 Nov; 39(11):835-840. PubMed ID: 29151290
    [No Abstract]   [Full Text] [Related]  

  • 8. Anthracycline dose optimisation in patients with diffuse large B-cell lymphoma: a multicentre, phase 3, randomised, controlled trial.
    Xu PP; Fu D; Li JY; Hu JD; Wang X; Zhou JF; Yu H; Zhao X; Huang YH; Jiang L; Liu F; Su LP; Chen ZW; Zeng QS; Chen JP; Fang MY; Ma J; Liu T; Song YP; Yu K; Li Y; Qiu LG; Chen XQ; Gu J; Yan JS; Hou M; Huang HY; Wang L; Cheng S; Shen Y; Xiong H; Chen SJ; Zhao WL
    Lancet Haematol; 2019 Jun; 6(6):e328-e337. PubMed ID: 31126528
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cumulative anthracycline exposure and risk of cardiotoxicity; a Danish nationwide cohort study of 2440 lymphoma patients treated with or without anthracyclines.
    Baech J; Hansen SM; Lund PE; Soegaard P; Brown PN; Haaber J; Jørgensen J; Starklint J; Josefsson P; Poulsen CB; Juul MB; Torp-Pedersen C; El-Galaly TC
    Br J Haematol; 2018 Dec; 183(5):717-726. PubMed ID: 30406945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Addition of rituximab to chop does not increase the risk of cardiotoxicity in patients with non-Hodgkin's lymphoma.
    Kilickap S; Yavuz B; Aksoy S; Sahiner L; Dincer M; Harputluoglu H; Erman M; Aytemir K; Tokgozoglu L; Barista I
    Med Oncol; 2008; 25(4):437-42. PubMed ID: 18415035
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Early detection of anthracycline cardiotoxicity and improvement with heart failure therapy.
    Cardinale D; Colombo A; Bacchiani G; Tedeschi I; Meroni CA; Veglia F; Civelli M; Lamantia G; Colombo N; Curigliano G; Fiorentini C; Cipolla CM
    Circulation; 2015 Jun; 131(22):1981-8. PubMed ID: 25948538
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New risk factors and new tendency for central nervous system relapse in patients with diffuse large B-cell lymphoma: a retrospective study.
    Cai QQ; Hu LY; Geng QR; Chen J; Lu ZH; Rao HL; Liu Q; Jiang WQ; Huang HQ; Lin TY; Xia ZJ
    Chin J Cancer; 2016 Sep; 35(1):87. PubMed ID: 27624700
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A Novel Predictor of Chemotherapeutic Cardiotoxicity in Patients with Non-Hodgkin Lymphoma.
    Gurdogan M; Ozkan U
    Oncol Res Treat; 2019; 42(7-8):375-381. PubMed ID: 31132772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Early cardiotoxicity of the CHOP regimen in aggressive non-Hodgkin's lymphoma.
    Limat S; Demesmay K; Voillat L; Bernard Y; Deconinck E; Brion A; Sabbah A; Woronoff-Lemsi MC; Cahn JY
    Ann Oncol; 2003 Feb; 14(2):277-81. PubMed ID: 12562656
    [TBL] [Abstract][Full Text] [Related]  

  • 15. High Sensitivity Troponin T as Complementary Modality for Determining Doxorubicin Regimen Cardiotoxicity in Non-Hodgkin Lymphoma Patients.
    Prayogo AA; Suryantoro SD; Savitri M; Hendrata WM; Wijaya AY; Pikir BS
    Adv Pharm Bull; 2022 Jan; 12(1):163-168. PubMed ID: 35517883
    [No Abstract]   [Full Text] [Related]  

  • 16. Anthracycline- and trastuzumab-induced cardiotoxicity: a retrospective study.
    Hamirani Y; Fanous I; Kramer CM; Wong A; Salerno M; Dillon P
    Med Oncol; 2016 Jul; 33(7):82. PubMed ID: 27334792
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cardiovascular adverse events in patients with non-Hodgkin lymphoma treated with first-line cyclophosphamide, doxorubicin, vincristine, and prednisone (CHOP) or CHOP with rituximab (R-CHOP): a systematic review and meta-analysis.
    Linschoten M; Kamphuis JAM; van Rhenen A; Bosman LP; Cramer MJ; Doevendans PA; Teske AJ; Asselbergs FW
    Lancet Haematol; 2020 Apr; 7(4):e295-e308. PubMed ID: 32135128
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Decline in Left Ventricular Ejection Fraction Following Anthracyclines Predicts Trastuzumab Cardiotoxicity.
    Goel S; Liu J; Guo H; Barry W; Bell R; Murray B; Lynch J; Bastick P; Chantrill L; Kiely BE; Abdi E; Rutovitz J; Asghari R; Sullivan A; Harrison M; Kohonen-Corish M; Beith J
    JACC Heart Fail; 2019 Sep; 7(9):795-804. PubMed ID: 31401102
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cardiotoxic Effect of Modern Anthracycline Dosing on Left Ventricular Ejection Fraction: A Systematic Review and Meta-Analysis of Placebo Arms From Randomized Controlled Trials.
    Jeyaprakash P; Sangha S; Ellenberger K; Sivapathan S; Pathan F; Negishi K
    J Am Heart Assoc; 2021 Mar; 10(6):e018802. PubMed ID: 33660514
    [TBL] [Abstract][Full Text] [Related]  

  • 20. R-COMP versus R-CHOP as first-line therapy for diffuse large B-cell lymphoma in patients ≥60 years: Results of a randomized phase 2 study from the Spanish GELTAMO group.
    Sancho JM; Fernández-Alvarez R; Gual-Capllonch F; González-García E; Grande C; Gutiérrez N; Peñarrubia MJ; Batlle-López A; González-Barca E; Guinea JM; Gimeno E; Peñalver FJ; Fuertes M; Bastos M; Hernández-Rivas JÁ; Moraleda JM; García O; Sorigué M; Martin A
    Cancer Med; 2021 Feb; 10(4):1314-1326. PubMed ID: 33492774
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.